Takeda is proud to team up with other public, private and non-government organizations for the launch of “The Fight Is In Us”, a campaign launched in the US that’s urging as many COVID-19 survivors as possible to join the fight against the disease. The initiative aims to mobilize tens of thousands of survivors to donate their blood plasma, which contains the vital antibodies that have helped them recover and could now help save the lives of others. Visit TheFightIsInUs.org. For those who live in Austria, Czechia, Germany, or Hungary, please visit www.CoVIg-19PlasmaAlliance.org for locations to donate plasma.
The key to beating COVID-19 could be found in its survivors.
Why? Because people who’ve successfully recovered from COVID-19 have developed antibodies against the virus that causes the disease. These antibodies are in their blood plasma and could be used to treat others.
How? Plasma collected from COVID-19 survivors can be used by Takeda and its partners in the CoVIg-19 Plasma Alliance to develop a potential medicine. Other organizations are using it for an alternative “direct transfusion” approach that is currently being administered to patients under temporary emergency use authorization from the FDA and is the subject of multiple safety and efficacy trials.
What has to happen? We need as many COVID-19 survivors as possible to donate their “convalescent” plasma and are directing them to more than 1,500 collection facilities associated with coalition members in the US, Austria, Czechia, Germany and Hungary. And we need them to do it quickly, while their antibodies are plentiful and most active, and before a predicted spike in COVID-19 cases this fall. It’s simple – the more plasma we collect and the quicker we collect it, the greater the impact we can have.
Who is involved? An unprecedented coalition of world-leading medical and research institutions, blood banks, life science and technology companies, philanthropic organizations and COVID-19 survivor groups has been formed to drive “The Fight Is In Us” campaign.
What is Takeda’s role? We initiated the CoVIg-19 Plasma Alliance in April 2020 to unite leading plasma industry efforts to tackle COVD-19, and are a founding member along with CSL-Behring. We have been collecting convalescent plasma since March and the first batch of CoVIg-19, the Alliance’s investigational hyperimmune globulin (H-Ig) medicine was initiated at Takeda’s Georgia manufacturing site in mid-May. It’s now also being manufactured at CSL Behring’s facility in Bern, Switzerland. CoVIg-19 is derived from the plasma of COVID-19 survivors, much of which has been donated at the Alliance’s established licensed collection facilities, including BioLife, in the U.S., Austria, Germany, Czechia and Hungary. Members of the CoVig-19 Plasma Alliance are also working with their local governments to source plasma to support development of CoVIg-19. If successful, our priority is equitable distribution and wide access of the medicine.
COLLABORATING TO CONQUER COVID-19
“The Fight Is In Us” coalition partners include:
“As an early survivor of COVID-19, I was desperate to do whatever was in my power to be a part of the solution. I started Survivor Corps to mobilize and connect the thousands of people affected by COVID-19 to support all ongoing scientific, medical and academic research, and this coalition is furthering our goal," said Diana Berrent, founder of Survivor Corps. "Inside COVID-19 survivors is the antibody-rich blood plasma that may help stem the tide of this pandemic. The time is now for superhero volunteers to donate their blood plasma and help stop COVID-19 in its tracks.”
Diana Berrent, Founder of Survivor Corps
We need you!
If you’ve recovered from COVID-19, or know someone who has, you may be able to help others survive by donating your plasma. It’s quick and easy – and it could make all the difference. If you live in US, Austria, Czechia, Germany or Hungary click to find a plasma donation facility near you.
“Across the plasma community, we have a common goal – to explore every potential opportunity that could lead to treatments for COVID-19. We are working together, and with partners outside our industry, because we know that our chances of success are better if we collaborate rather than pursue our individual work. But we’ll achieve nothing without the help of the public too. So please consider donating your convalescent plasma now. Or simply let your friends, family, neighbors and social media contacts know how they can contribute to this important public health campaign.
Join the fight, help save lives.”
Julie Kim, President, Plasma-Derived Therapies Business Unit
To learn more about how you can support this program, visit www.thefightisinus.org
See more about our progress on the campaign, visit https://www.takeda.com/covid-19-information-center/covig-19-plasma-alliance/